MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease

Background: RAI is used as definitive treatment for hyperthyroidism, but administered activities vary between institutions. We used a fixed activity of RAI therapy for Grave’s disease (GD) and toxic multinodular goitre (TMNG), and calculated activity for toxic adenoma (TA). We reviewed treatment out...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljenaee, Khaled, Ali, Sulaiman, Cooke, Jennie, Phelan, Niamh, Pazderska, Agnieszka, Healy, Marie-Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550630/
http://dx.doi.org/10.1210/js.2019-MON-590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550630/
http://dx.doi.org/10.1210/js.2019-MON-590

Ejemplares similares